Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868668 · ClinicalTrials.gov registry record · NA

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

A NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
186
Enrollment target
1
Study location

NCT05868668 is a NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 186 participants, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868668, a NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
186 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

Interventions

  • DEVICE Focused shockwave
  • DEVICE Radial wave
  • DEVICE Sham treatment

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 186 participants
Start Date 2023-09-19
Est. Completion 2026-06
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT05868668

The ClinicalTrials.gov registry entry for NCT05868668 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (18% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Focused shockwave is the first listed.

NCT05868668 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05868668 about?

NCT05868668 is a clinical study titled "Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain". The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

What is the current status of trial NCT05868668?

This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2023-09-19. Estimated completion is 2026-06.

What conditions does trial NCT05868668 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Chronic Pelvic Pain Syndrome, Erectile Dysfunction Following Radical Prostatectomy, Chronic Prostatitis, Erectile Dysfunction Due to Arterial Insufficiency.

What interventions are being tested in trial NCT05868668?

The interventions under investigation include: Focused shockwave (DEVICE), Radial wave (DEVICE), Sham treatment (DEVICE).

Who is sponsoring clinical trial NCT05868668?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868668 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.